These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

934 related items for PubMed ID: 8836881

  • 1. Non-RGD domains of osteopontin promote cell adhesion without involving alpha v integrins.
    Katagiri YU, Murakami M, Mori K, Iizuka J, Hara T, Tanaka K, Jia WY, Chambers AF, Uede T.
    J Cell Biochem; 1996 Jul; 62(1):123-31. PubMed ID: 8836881
    [Abstract] [Full Text] [Related]

  • 2. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.
    Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L.
    Mol Biol Cell; 1994 May; 5(5):565-74. PubMed ID: 7522656
    [Abstract] [Full Text] [Related]

  • 3. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions.
    Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF.
    J Cell Biochem; 1995 Apr; 57(4):680-90. PubMed ID: 7542253
    [Abstract] [Full Text] [Related]

  • 4. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5.
    Hu DD, Lin EC, Kovach NL, Hoyer JR, Smith JW.
    J Biol Chem; 1995 Nov 03; 270(44):26232-8. PubMed ID: 7592829
    [Abstract] [Full Text] [Related]

  • 5. Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment.
    van Dijk S, D'Errico JA, Somerman MJ, Farach-Carson MC, Butler WT.
    J Bone Miner Res; 1993 Dec 03; 8(12):1499-506. PubMed ID: 8304052
    [Abstract] [Full Text] [Related]

  • 6. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V, Wei H, Ego-Osuala D, Chellaiah MA.
    Exp Cell Res; 2006 Jul 15; 312(12):2214-30. PubMed ID: 16631740
    [Abstract] [Full Text] [Related]

  • 7. Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin.
    Senger DR, Perruzzi CA.
    Biochim Biophys Acta; 1996 Nov 08; 1314(1-2):13-24. PubMed ID: 8972713
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin.
    Bautista DS, Xuan JW, Hota C, Chambers AF, Harris JF.
    J Biol Chem; 1994 Sep 16; 269(37):23280-5. PubMed ID: 8083234
    [Abstract] [Full Text] [Related]

  • 9. Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha v-subunit.
    Chellaiah M, Fitzgerald C, Filardo EJ, Cheresh DA, Hruska KA.
    Endocrinology; 1996 Jun 16; 137(6):2432-40. PubMed ID: 8641196
    [Abstract] [Full Text] [Related]

  • 10. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
    Chang PL, Chambers AF.
    J Cell Biochem; 2000 Apr 16; 78(1):8-23. PubMed ID: 10797562
    [Abstract] [Full Text] [Related]

  • 11. Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin.
    Bayless KJ, Davis GE.
    J Biol Chem; 2001 Apr 20; 276(16):13483-9. PubMed ID: 11278897
    [Abstract] [Full Text] [Related]

  • 12. Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion.
    Xuan JW, Hota C, Chambers AF.
    J Cell Biochem; 1994 Feb 20; 54(2):247-55. PubMed ID: 8175899
    [Abstract] [Full Text] [Related]

  • 13. Ca2+ suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin alpha v beta 3.
    Hu DD, Hoyer JR, Smith JW.
    J Biol Chem; 1995 Apr 28; 270(17):9917-25. PubMed ID: 7537271
    [Abstract] [Full Text] [Related]

  • 14. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin.
    Yokosaki Y, Matsuura N, Sasaki T, Murakami I, Schneider H, Higashiyama S, Saitoh Y, Yamakido M, Taooka Y, Sheppard D.
    J Biol Chem; 1999 Dec 17; 274(51):36328-34. PubMed ID: 10593924
    [Abstract] [Full Text] [Related]

  • 15. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
    Allan AL, George R, Vantyghem SA, Lee MW, Hodgson NC, Engel CJ, Holliday RL, Girvan DP, Scott LA, Postenka CO, Al-Katib W, Stitt LW, Uede T, Chambers AF, Tuck AB.
    Am J Pathol; 2006 Jul 17; 169(1):233-46. PubMed ID: 16816376
    [Abstract] [Full Text] [Related]

  • 16. Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin.
    Chambers AF, Hota C, Prince CW.
    Cancer Res; 1993 Feb 01; 53(3):701-6. PubMed ID: 8425206
    [Abstract] [Full Text] [Related]

  • 17. Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin.
    Smith LL, Giachelli CM.
    Exp Cell Res; 1998 Jul 10; 242(1):351-60. PubMed ID: 9665832
    [Abstract] [Full Text] [Related]

  • 18. The integrin specificity of human recombinant osteopontin.
    Caltabiano S, Hum WT, Attwell GJ, Gralnick DN, Budman LJ, Cannistraci AM, Bex FJ.
    Biochem Pharmacol; 1999 Nov 15; 58(10):1567-78. PubMed ID: 10535747
    [Abstract] [Full Text] [Related]

  • 19. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
    Razzouk S, Brunn JC, Qin C, Tye CE, Goldberg HA, Butler WT.
    Bone; 2002 Jan 15; 30(1):40-7. PubMed ID: 11792563
    [Abstract] [Full Text] [Related]

  • 20. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
    Sung V, Stubbs JT, Fisher L, Aaron AD, Thompson EW.
    J Cell Physiol; 1998 Sep 15; 176(3):482-94. PubMed ID: 9699501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.